Physician profile
Rikin S Kadakia
NPI 1154718526
$238,386.06
in general payments reported to CMS, 2019-2025
50 companies · $116K in 2025
The $116K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $595 · 2021: $1,903 · 2022: $6,220 · 2023: $6,514 · 2024: $107K · 2025: $116K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $123K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $35K · Travel and Lodging: $32K · Food and Beverage: $20K · Consulting Fee: $19K · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $122,934.44 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $35,200.00 |
| Travel and Lodging | $31,885.76 |
| Food and Beverage | $19,799.09 |
| Consulting Fee | $19,282.00 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $137,856.07 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Shockwave Medical, INC | $79,345.60 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $3,941.87 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,781.77 | 2022-2025 | Mitraclip, Triclip, Cardiomems |
| Abiomed | $1,975.50 | 2022-2025 | Impella |
| Medtronic, INC. | $1,807.86 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Biotronik INC. | $1,125.26 | 2021-2023 | Orsiro Mission, Nhancer Rx, Trapit |
| Boston Scientific Corporation | $1,046.09 | 2020-2025 | Opticross, Watchman Access System, Rotapro |
| Astrazeneca Pharmaceuticals Lp | $914.61 | 2019-2025 | Farxiga, Andexxa |
| Inari Medical, INC. | $779.04 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $773.46 | 2021-2023 | Diamondback Peripheral, Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $716.82 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $619.09 | 2020-2025 | Eliquis, Camzyos |
| Cook Medical LLC | $479.71 | 2022-2023 | Cook |
| Pfizer INC. | $417.64 | 2019-2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $393.56 | 2023-2025 | Verquvo, Capvaxive |
| Chiesi USA, INC. | $369.53 | 2022-2023 | Kengreal, Cleviprex |
| Novartis Pharmaceuticals Corporation | $330.96 | 2023-2025 | |
| Astellas Pharma US INC | $288.68 | 2021 | |
| Philips North America LLC | $279.80 | 2021-2025 | Extended Holter, (5050) Ext Holter |
| Amgen INC. | $262.70 | 2020-2025 | Repatha, Repatha |
| W. L. Gore & Associates, INC. | $248.86 | 2022-2025 | Gore Cardioform Septal Occluder, Gore Viabahn Vbx Balloon Expandable Endo |
| Terumo Medical Corporation | $207.07 | 2022 | |
| Penumbra, INC. | $120.23 | 2024 | Indigo System |
| Alnylam Pharmaceuticals INC. | $118.15 | 2019 | |
| Lantheus Medical Imaging, INC. | $113.49 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $99.20 | 2024 | Arcalyst |
| Jenavalve Technology, INC. | $97.62 | 2023 | Jenavalve Pericardial Tavr System |
| Bayer Healthcare Pharmaceuticals INC. | $87.70 | 2024-2025 | |
| Baxter Healthcare | $81.89 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.06 | 2023-2024 | Jardiance |
| Esperion Therapeutics, INC. | $76.34 | 2021-2025 | Nexletol |
| Teleflex LLC | $68.97 | 2022 | |
| Irhythm Technologies, INC. | $58.20 | 2024 | Zio Xt Patch, Zio Monitor |
| Livanova USA, INC. | $55.22 | 2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $39.36 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $36.11 | 2024 | Savvywire |
| Ge Healthcare | $33.17 | 2024 | |
| Becton, Dickinson and Company | $29.88 | 2024 | Arista Ah Flexitip |
| Getinge USA Sales, LLC | $25.82 | 2023 | Cardiosave Hybrid, Type B Plug |
| Janssen Pharmaceuticals, INC | $25.00 | 2024 | Xarelto |
| Bridgebio Pharma, INC. | $24.25 | 2025 | Attruby |
| Trevena, INC. | $24.02 | 2022 | |
| Lilly USA, LLC | $23.89 | 2025 | Mounjaro, Zepbound |
| Scpharmaceuticals INC. | $23.61 | 2025 | |
| Sanofi-Aventis U.S. LLC | $20.00 | 2023 | |
| Viiv Healthcare Company | $17.81 | 2024 | Cabenuva |
| Atricure, INC. | $16.64 | 2024 | |
| Cleerly, INC. | $14.06 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Reflow Medical INC | $13.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rikin Kadakia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.